RGLS4326
| Code | Size | Price |
|---|
| TAR-T39712-5mg | 5mg | £850.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Documents
Further Information
Bioactivity:
RGLS4326 (RG4326) is a first-in-class, short oligonucleotide inhibitor of microRNA-17 ( miR-17 ). RGLS4326 can be used for the research of autosomal dominant polycystic kidney disease (ADPKD). RGLS4326 inhibits miR-17 function in HeLa cells with an EC 50 value of 28.3 nM.
CAS:
2229964-07-0
Formula:
0
Molecular Weight:
0
Purity:
0.98
SMILES:
0
References
Edmund C Lee, et al. Discovery and preclinical evaluation of anti-miR-17 oligonucleotide RGLS4326 for the treatment of polycystic kidney disease. Nat Commun.?2019 Sep 12;10(1):4148.